STOCK TITAN

Fosun International Stock Price, News & Analysis

FOSUF OTC Link

Company Description

Fosun International Limited (traded over-the-counter as FOSUF) is described as operating in the Offices of Bank Holding Companies industry within the broader Management of Companies and Enterprises sector. According to available information, Fosun has developed into a global innovation-driven consumer group with business activities spanning health, cultural tourism, consumption, financial services, insurance, and related areas.

Fosun states that it adheres to a mission of creating happier lives for families worldwide and is committed to building a global ecosystem around health, happiness, and wealth. Over more than three decades of development, the group has expanded its presence to numerous countries and regions and has emphasized combining a global perspective with localized operations. Its activities include pharmaceuticals and healthcare, cultural tourism and consumption, and financial services and insurance, among other business lines mentioned in public communications.

Business focus and core segments

Based on company disclosures, Fosun concentrates resources on several core business segments. In health-related businesses, it highlights biopharmaceuticals, innovative drugs, medical devices, and healthcare services through member companies such as Fosun Pharma and Henlius. In cultural tourism and consumption, it references operations such as Fosun Tourism Group and activities in areas like resorts, cultural events, and branded consumer offerings. In financial services and insurance, the group includes operations such as Fosun Insurance Portugal and asset servicing activities in Europe.

Fosun has communicated a strategy of streamlining non-core assets while focusing on industries where it believes it has significant advantages, including biopharmaceuticals, cultural tourism, insurance, and healthcare. It also emphasizes an asset-light operating approach in parts of its portfolio, such as retaining asset servicing businesses while divesting certain banking operations.

Innovation and globalization themes

Public statements repeatedly describe innovation and globalization as central themes in Fosun's development. In pharmaceuticals, the group points to innovative drugs and therapies developed or commercialized through its health segment, including oncology and rare disease treatments, as well as medical devices and diagnostic technologies. It highlights global research and development platforms, regulatory capabilities, and business development activities across multiple regions.

On globalization, Fosun notes that it has maintained a presence in many countries and regions and that a significant portion of its revenue is generated outside its home market. It has referred to combining China's capabilities with global assets, integrating global resources, and expanding into emerging markets through partnerships and investments in areas such as healthcare, tourism, mining, and financial services.

ESG and sustainability positioning

Fosun publicly emphasizes environmental, social, and governance (ESG) performance. The group reports participation in global sustainability assessments and notes that it has been recognized in ESG-related ratings and yearbooks. It has disclosed initiatives such as climate information reporting, carbon neutrality goals, and internal governance structures for carbon management. Social programs mentioned include support for rural doctors in China and contributions to the global fight against malaria through the supply of artesunate for injection.

These ESG-related activities are presented as part of Fosun's long-standing value of "Contribution to Society" and its sustainable development strategy. The company notes that it integrates ESG considerations into management systems and performance assessments and that member companies participate in climate and sustainability discussions at international forums.

Corporate development and portfolio management

Fosun describes itself as actively managing its asset portfolio. It has communicated the sale of certain financial institutions, such as a German private bank, while retaining related asset servicing businesses that align with its asset-light strategy. At the same time, it reports increased investment in core sectors, including biopharmaceuticals, cultural tourism, insurance, and healthcare.

The group also refers to building synergies across its global industrial ecosystem, for example by linking insurance, asset management, and asset servicing in Europe, or by leveraging tourism and cultural assets to promote Chinese culture internationally. It presents this approach as a way to enhance operational efficiency and long-term value creation.

Use of technology and artificial intelligence

Fosun indicates that it is incorporating digital technologies and artificial intelligence (AI) into multiple business scenarios. In healthcare, it mentions decision intelligence platforms that integrate clinical and pipeline data to support research and development and commercial decision-making. In cultural tourism, it refers to conversational AI assistants and AI-based systems designed to improve the vacation experience and operational efficiency. In financial services, it notes AI applications aimed at improving process efficiency and data accuracy.

According to the company, these AI and digital initiatives are intended to support innovation, enhance customer experience, and create new growth points across its health, tourism, consumption, and financial services businesses.

Corporate citizenship and social initiatives

Fosun highlights several social responsibility initiatives. In healthcare, it points to its role in supplying artesunate for injection to treat severe malaria patients worldwide and to the development of second-generation formulations aimed at improving clinical convenience in regions with limited medical infrastructure. In rural China, it has launched programs to support rural doctors and improve primary healthcare services, including the development of AI-assisted tools based on clinical reference materials.

The company also notes cultural and educational initiatives, such as international cultural events and support for youth development, which it presents as part of its broader "business for good" philosophy. These activities are framed as aligning commercial development with contributions to public health, rural revitalization, and cultural exchange.

Position within its stated industry classification

While industry data classifies FOSUF under Offices of Bank Holding Companies and the Management of Companies and Enterprises sector, the company's own public communications emphasize its role as a global consumer group with diversified interests in health, tourism, consumption, and financial and insurance services. Investors researching FOSUF should be aware that this classification reflects how industry databases categorize the entity, while the company's disclosures describe a broader conglomerate structure with multiple operating subsidiaries and investments.

Frequently asked questions about Fosun (FOSUF)

Stock Performance

$—
0.00%
0.00
Last updated:
-21.05%
Performance 1 year

Fosun International (FOSUF) stock last traded at $0.4342. Over the past 12 months, the stock has lost 21.1%. At a market capitalization of $3.5B, FOSUF is classified as a mid-cap stock with approximately 8.2B shares outstanding.

SEC Filings

No SEC filings available for FOSUF.

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

SEP
01
September 1, 2028 Financial

Syndicated loan maturity

3-year USD 990M sustainability-linked syndicated loan maturing (origin Sept 2025)
DEC
31
December 31, 2028 Corporate

Emissions peak target

Company target to reach peak emissions by 2028 (company-wide goal)
DEC
31
December 31, 2050 Corporate

Carbon neutrality target

Company target to achieve carbon neutrality by 2050

Fosun International has 3 upcoming scheduled events. The next event, "Syndicated loan maturity", is scheduled for September 1, 2028 (in 877 days). 1 of the upcoming events are financial in nature, such as earnings calls or quarterly results. Investors can track these dates to stay informed about potential catalysts that may affect the FOSUF stock price.

Short Interest History

Last 12 Months

Short interest in Fosun International (FOSUF) currently stands at 30.3 thousand shares, down 94.4% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 94.2%. This relatively low short interest suggests limited bearish sentiment. With 1000.0 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.

Days to Cover History

Last 12 Months

Days to cover for Fosun International (FOSUF) currently stands at 1000.0 days. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The ratio has shown significant volatility over the period, ranging from 105.6 to 1000.0 days.

FOSUF Company Profile & Sector Positioning

Fosun International (FOSUF) operates in the Conglomerates industry within the broader Industrials sector and is listed on the OTC Link.

Investors comparing FOSUF often look at related companies in the same sector, including Fosun Internatio (FOSUY), TOPPAN Holdings (TOPPY), Kyocera (KYOCY), Orbia Advance (MXCHF), and Marubeni Corp (MARUY). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate FOSUF's relative position within its industry.

Frequently Asked Questions

What is the current stock price of Fosun International (FOSUF)?

The current stock price of Fosun International (FOSUF) is $0.434216 as of December 31, 2025.

What is the market cap of Fosun International (FOSUF)?

The market cap of Fosun International (FOSUF) is approximately 3.5B. Learn more about what market capitalization means .

What does Fosun International (FOSUF) do?

According to its public communications, Fosun International is a global innovation-driven consumer group with activities across health, cultural tourism, consumption, financial services, insurance, and related areas. Industry data classifies FOSUF in the Offices of Bank Holding Companies industry within the Management of Companies and Enterprises sector.

How is Fosun classified by industry and sector?

Available classification data places Fosun International (FOSUF) in the Offices of Bank Holding Companies industry and the Management of Companies and Enterprises sector. At the same time, the company describes itself as a global consumer group focused on health, happiness, and wealth for families worldwide.

What are Fosun’s core business segments?

Fosun states that it focuses on core segments including pharmaceuticals and healthcare, cultural tourism and consumption, and financial services and insurance. It has highlighted member companies such as Fosun Pharma, Yuyuan, Fosun Insurance Portugal, and Fosun Tourism Group as important contributors within these areas.

How does Fosun describe its growth strategy?

Fosun describes a strategy of concentrating on core industries where it believes it has advantages, such as biopharmaceuticals, cultural tourism, insurance, and healthcare, while divesting from certain non-core or asset-heavy projects. It emphasizes innovation, globalization, and an asset-light operating approach in parts of its portfolio.

What role does innovation play in Fosun’s business?

Fosun repeatedly identifies innovation as a core driving force. In its health segment, it highlights innovative drugs, therapies, medical devices, and diagnostic technologies. It also refers to AI-driven digital transformation in areas such as pharmaceuticals, cultural tourism, and insurance, and to global research and development platforms and business development capabilities.

How does Fosun approach globalization?

The company states that it has maintained a presence in many countries and regions and that a significant share of its revenue is generated overseas. It describes a transition from combining China’s growth momentum with global resources to integrating China’s capabilities with global assets, and it reports expansion into emerging markets through partnerships and investments.

What ESG and sustainability initiatives has Fosun highlighted?

Fosun reports participation in ESG ratings and sustainability assessments and notes recognition in ESG-related yearbooks and indices. It has disclosed climate information reports, carbon neutrality goals, and governance structures such as a Carbon Neutrality Committee and Working Group. Social initiatives include the Rural Doctors Program in China and the global supply of artesunate for injection to treat severe malaria.

What social responsibility programs does Fosun mention?

Fosun points to several programs, including long-term support for rural doctors in China through the Rural Doctors Program and contributions to the global fight against malaria by supplying artesunate for injection and a second-generation formulation called Argesun. It also mentions cultural and educational initiatives supported through Fosun Foundation.

How is Fosun using artificial intelligence in its businesses?

Fosun reports that it is applying AI in multiple areas. Examples include the PharmAID decision intelligence platform in pharmaceuticals, which integrates clinical and pipeline data; conversational AI assistants and an AI-based cultural tourism system in its tourism businesses; and AI applications in insurance operations to improve efficiency and data accuracy.

What is Fosun’s approach to portfolio management and asset optimization?

The company describes ongoing portfolio optimization, including the sale of certain assets such as a German private bank while retaining related asset servicing businesses that fit an asset-light model. It states that it will continue to exit some non-core or asset-heavy projects and increase investment in industries where it sees key competitive advantages, such as biopharmaceuticals, cultural tourism, insurance, and healthcare.